In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP)
Open Access
- 5 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-15
- https://doi.org/10.1038/s41598-021-84622-x
Abstract
Plasmodium falciparum malaria contributes to a significant global disease burden. Circumsporozoite protein (CSP), the most abundant sporozoite stage antigen, is a prime vaccine candidate. Inhibitory monoclonal antibodies (mAbs) against CSP map to either a short junctional sequence or the central (NPNA)n repeat region. We compared in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a recombinant CSP vaccine RTS,S/AS01 (mAbs 317 and 311); an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria (mAbs 580 and 663). RTS,S mAb 317 that specifically binds the (NPNA)n epitope, had the highest affinity and it elicited the best sterile protection in mice. The most potent inhibitor of sporozoite invasion in vitro was mAb CIS43 which shows dual-specific binding to the junctional sequence and (NPNA)n. In vivo mouse protection was associated with the mAb reactivity to the NANPx6 peptide, the in vitro inhibition of sporozoite invasion activity, and kinetic parameters measured using intact mAbs or their Fab fragments. Buried surface area between mAb and its target epitope was also associated with in vivo protection. Association and disconnects between in vitro and in vivo readouts has important implications for the design and down-selection of the next generation of CSP based interventions.Funding Information
- U.S. Department of Defense (MIDRP, MIDRP, MIDRP, MIDRP, MIDRP, MIDRP, MIDRP, MIDRP)
- United States Agency for International Development (AID-GHA-T-00-08-00007, AID-GHA-T-00-08-00007, AID-GHA-T-00-08-00007, AID-GHA-T-00-08-00007)
- Bill and Melinda Gates Foundation (OPP1151372, OPP1151372)
This publication has 68 references indexed in Scilit:
- Complete Plasmodium falciparum liver-stage development in liver-chimeric miceJCI Insight, 2012
- Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoitesMolecular and Biochemical Parasitology, 2012
- Unexpected fold in the circumsporozoite protein target of malaria vaccinesProceedings of the National Academy of Sciences of the United States of America, 2012
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza VaccinesScience Translational Medicine, 2011
- The malaria circumsporozoite protein has two functional domains, each with distinct roles as sporozoites journey from mosquito to mammalian hostThe Journal of Experimental Medicine, 2011
- Alanine Mutagenesis of the Primary Antigenic Escape Residue Cluster, C1, of Apical Membrane Antigen 1Infection and Immunity, 2010
- Structure of the Plasmodium falciparum Circumsporozoite Protein, a Leading Malaria Vaccine CandidateOnline Journal of Public Health Informatics, 2009
- Binding induced conformational changes of proteins correlate with their intrinsic fluctuations: a case study of antibodiesBMC Structural Biology, 2007
- Plasmodium sporozoites trickle out of the injection siteCellular Microbiology, 2006
- The CCP4 suite: programs for protein crystallographyActa crystallographica. Section D, Structural biology, 1994